Use in the Elderly: Elderly and debilitated prolonged effect of lorazepam due to increased half-life and decreased total clearance.
Elderly. Following single intravenous doses of 1.5 to 3 mg of Lorazepam Injection, mean total body clearance of lorazepam decreased by 20% in 15 elderly
Elderly. Following single intravenous doses of 1.5 to 3 mg of Lorazepam injection, mean total body clearance of lorazepam decreased by 20% in 15 elderly
Elderly. Following single intravenous doses of 1.5 to 3 mg of Lorazepam injection, mean total body clearance of lorazepam decreased by 20% in 15 elderly
Elderly. Following single intravenous doses of 1.5 to 3 mg of Lorazepam Injection, mean total body clearance of lorazepam decreased by 20% in 15 elderly
Elderly. Following single intravenous doses of 1.5 to 3 mg of Lorazepam Injection, mean total body clearance of lorazepam decreased by 20% in 15 elderly
Elderly. Following single intravenous doses of 1.5 to 3 mg of Lorazepam Injection, mean total body clearance of lorazepam decreased by 20% in 15 elderly
In elderly patients - lorazepam should be used with caution due to the risk of Lorazepam (last accessed on. ). Organisation and individual
should not take this medicine. Elderly patients. Lorazepam should be used with caution in elderly due to the risk of sedation and/or
Comments